The Government of Victoria in Australia has broken ground on the new melanoma and clinical trials centre.

To be named the Paula Fox Melanoma and Cancer Centre, the construction of the $105.4m (A$152m) facility is currently progressing. 

It will be situated beside the Alfred Hospital on St Kilda Road. 

The facility will offer expert researchers, clinical care and cancer patient treatment facilities at one-stop and will steer innovation in oncology research and deliver comprehensive skin cancer care services.

Demolition works at the location have been completed allowing the construction on the centre to start. 

The hospital and research centre are anticipated to become operational in 2024.

The Labor Government is extending a sum of $34.7m ($50m) to the new centre, which will house the Victorian Melanoma Service, Alfred Cancer Services and the Australian Clinical Trials Centre.

In addition, the Commonwealth Government has offered $34.7m (A$50m) for the centre.

The facility is part of Alfred Health’s ‘TrialHub’ programme, which connects Victorians in the rural and regional areas to clinical trial opportunities.

Melanoma, oncology, clinical trials and research operations will be co-located at the centre and back TrialHub initiatives underway, including melanoma trials.

For screening, analysis and treatment of the patients, the new centre will have a capacity for about 300 patients each day, across 49 chemotherapy treatment chairs and 25 clinic rooms.

Clinical trials in Victoria contribute over $208m (A$300m) to the economy of the state every year.

Premier of Victoria Daniel Andrews said: “With a great partner in Canberra, we’ll deliver a world-class Melanoma Centre in St Kilda to prevent, detect and treat skin cancers – as we continue to put patients first.”

“This specialist centre will enhance cancer care and expand clinical trials, so every Victorian patient can get the care they need, close to home.”